Frank Douglas

Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.

Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland.

ALTANA Pharma AG develops and manufactures pharmaceuticals. It provides services in the areas of therapeutics, imaging and OTC medication. The company is headquartered in Konstanz, Germany.

Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts.

Alantos Pharmaceuticals AG develops and manufactures molecule pharmaceuticals for arthritic and metabolic diseases. The company was founded in 1999 and is headquartered in Heidelberg, Germany.

Ewing Marion Kauffman Foundation operates as a private, nonpartisan foundation that works in entrepreneurship and education to create uncommon solutions and connect people to the tools they need to shape their futures and be successful. It works with partners to encourage entrepreneurship across America and improve the education of children and youth. It works with educators and researchers nationwide to create awareness of economic impact of entrepreneurship. The company was founded by Ewing Marion Kauffman in 1966 and is headquartered in Kansas City, MO.

The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT.

Multiple Myeloma Research Foundation, the mission of the MMRF is to accelerate the development of novel and combination treatments for patients with multiple myeloma by promoting and facilitating collaborative research between industry and academia. The MMRC is led by an exceptional Leadership Team, including a full scientific and clinical staff, which is headquartered in Norwalk, Conn

Part of Battelle Memorial Institute, Battelle Corp. provides atmospheric research. The private company is based in Columbus, OH. Lewis F. von Thaer has been the CEO of the company since 2017.

Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA.

Enlight Biosciences LLC develops research tools for drug discovery and development. It offers patient-centric platforms that may impact all aspects of the connected health ecosystem from patient engagement and experience, to patient-focused research and development. The company was founded by Raju S. Kucherlapati, David Steinberg, Rakesh Kumar Jain, H. Robert Horbitz, and Sanjiv Sam Gambhir in July 2008 and is headquartered in Boston, MA.

MIT Center for Biomedical Innovation improves global health by overcoming obstacles to the development and implementation of biomedical innovation. Its programs include Biomanufacturing Program, Consortium on Adventitious Agent Contamination in Biomanufacturing and New Drug Development Paradigms program. The company was founded by Frank Lennox Douglas in 2005 and is headquartered in Cambridge, MA.

TheVax Genetics Vaccine Co., Ltd. engages in the manufacture, research, and development of human vaccines. Its products include PEK fusion proteins such as TVGV-1 designed for the treatment of human papilloma virus (HPV). It also engages in the research of innovative health control solutions and provides biotechnology services. The company was founded by Hsiu Kang Chang on June 27, 2012 and is headquartered in Taipei, Taiwan.

Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA.